Tag: Hatch-Waxman Act
Brand companies launch authorized generics not to help patients, but to protect revenue when patents expire. These are identical drugs sold under a generic label, cutting prices while keeping market share - a strategic move that lowers costs for consumers and reshapes generic competition.
- Read More